22
Participants
Start Date
July 23, 2019
Primary Completion Date
July 31, 2022
Study Completion Date
July 31, 2022
Flecainide Pill
Flecainide pill or placebo 100 mg administered twice a day for 4 weeks each
Placebo
Flecainide pill or placebo 100 mg administered twice a day for 4 weeks each
New York University, New York
University of Rochester Medical Center, Rochester
University of Pensylvania, Philadelphia
John Hopkins University, Baltimore
Duke University, Durham
University of Colorado, Denver
National Heart, Lung, and Blood Institute (NHLBI)
NIH
University of Rochester
OTHER